HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pediatric neurological syndromes and inborn errors of purine metabolism.

Abstract
This review is devised to gather the presently known inborn errors of purine metabolism that manifest neurological pediatric syndromes. The aim is to draw a comprehensive picture of these rare diseases, characterized by unexpected and often devastating neurological symptoms. Although investigated for many years, most purine metabolism disorders associated to psychomotor dysfunctions still hide the molecular link between the metabolic derangement and the neurological manifestations. This basically indicates that many of the actual functions of nucleosides and nucleotides in the development and function of several organs, in particular central nervous system, are still unknown. Both superactivity and deficiency of phosphoribosylpyrophosphate synthetase cause hereditary disorders characterized, in most cases, by neurological impairments. The deficiency of adenylosuccinate lyase and 5-amino-4-imidazolecarboxamide ribotide transformylase/IMP cyclohydrolase, both belonging to the de novo purine synthesis pathway, is also associated to severe neurological manifestations. Among catabolic enzymes, hyperactivity of ectosolic 5'-nucleotidase, as well as deficiency of purine nucleoside phosphorylase and adenosine deaminase also lead to syndromes affecting the central nervous system. The most severe pathologies are associated to the deficiency of the salvage pathway enzymes hypoxanthine-guanine phosphoribosyltransferase and deoxyguanosine kinase: the former due to an unexplained adverse effect exerted on the development and/or differentiation of dopaminergic neurons, the latter due to a clear impairment of mitochondrial functions. The assessment of hypo- or hyperuricemic conditions is suggestive of purine enzyme dysfunctions, but most disorders of purine metabolism may escape the clinical investigation because they are not associated to these metabolic derangements. This review may represent a starting point stimulating both scientists and physicians involved in the study of neurological dysfunctions caused by inborn errors of purine metabolism with the aim to find novel therapeutical approaches.
AuthorsMarcella Camici, Vanna Micheli, Piero Luigi Ipata, Maria Grazia Tozzi
JournalNeurochemistry international (Neurochem Int) Vol. 56 Issue 3 Pg. 367-78 (Feb 2010) ISSN: 1872-9754 [Electronic] England
PMID20005278 (Publication Type: Journal Article, Review)
CopyrightCopyright (c) 2009 Elsevier Ltd. All rights reserved.
Chemical References
  • Enzymes
  • Nucleotides
  • Purines
Topics
  • Age Factors
  • Brain Diseases, Metabolic, Inborn (metabolism, pathology, physiopathology)
  • Central Nervous System (growth & development, metabolism, physiopathology)
  • Child
  • Child, Preschool
  • Enzymes (metabolism)
  • Humans
  • Infant
  • Infant, Newborn
  • Metabolic Networks and Pathways (physiology)
  • Neurons (metabolism, pathology)
  • Nucleotides (metabolism)
  • Purine-Pyrimidine Metabolism, Inborn Errors (metabolism, pathology, physiopathology)
  • Purines (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: